Legal Representation
Attorney
John L. DuPre'
USPTO Deadlines
Next Deadline
59 days remaining
Non-Final Action Mailed
Due Date
January 06, 2026
Extension Available
Until April 06, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 6, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 6, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 6, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 11, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 17, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 17, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for human use for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; pharmaceutical preparations for medical and therapeutic purposes for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders
Class 042
Providing scientific and technological information, namely, results from medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; Providing scientific information, namely, results from pharmaceutical, biomedical and biological therapeutic research; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields for treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; research and development of therapeutics
Class 044
Providing information relating to the diagnostic, prophylactic, and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of human and veterinary neurological, neurodegenerative and other central nervous system diseases, disorders, and conditions
Classification
International Classes
005
042
044